Skip to main content
Log in

The Effect of Afobazole and Levodopa on Activity of Proline-Specific Proteinases and Adenosine Deaminase in Serum and Brain Structures of Rats with Experimental Parkinsonism Induced by Systemic Administration of Rotenone

  • Published:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry Aims and scope Submit manuscript

Abstract

Rats with experimental parkinsonism induced by intraperitoneal daily administration of rotenone (2.75 mg/kg) during seven days are characterized by an increased activity of prolyl endopeptidase (PEP; ЕС 3.4.21.26) in serum and a decreased activity of adenosine deaminase (ADA; EC 3.5.4.4) in serum and in the prefrontal cortex. PEP and ADA activities in other brain structures (in the striatum, hypothalamus, and hippocampus) as well as activity of dipeptidyl peptidase IV (DPP-4, CD26; ЕС 3.4.14.5) in serum and in all the brain structures investigated remained unchanged. Afobazole and levodopa, which exhibit antiparkinsonian activity in this model of parkinsonism, decreased the elevated PEP activity in serum and increased ADA activity reduced in the prefrontal cortex of rats with the experimental pathology. At the same time, treatment with these drugs resulted in a decrease of ADA activity in the other brain structures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Duty, S. and Jenner, P., Br. J. Pharmacol., 2011, vol. 164, pp. 1357–1391. doi 10.1111/j.1476-5381. 2011.01426.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Brandt, I., Gerard, M., Sergeant, K., Devreese, B., Baekelandt, V., Augustyns, K., Scharpe, S., Engelborghs, Y., and Lambeir, A.M., Peptides, 2008, vol. 29, pp. 1472–1478. doi 10.1016/j.peptides.2008.05.005

    Article  CAS  PubMed  Google Scholar 

  3. Myöhänen, T.T., Hannula, M.J., Van Elzen, R., Gerard, M., Van Der Veken, P., García-Horsman, J.A., Baekelandt, V., Männistö, P.T., and Lambeir, A.M., Br. J. Pharmacol., 2012, vol. 166, no. 3, pp. 1097–1113. doi 10.1111/j.1476-5381.2012.01846.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sedo, A., Duke-Cohan, J.S., Balaziova, E., and Sedova, L.R., Arthritis. Res. Ther., 2005, vol. 7, no. 6, pp. 253–269. doi 10.1186/ar1852

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ferre, S., Herrera-Marschitz, M., Grabowska-Anden, M., Ungerstedt, U., Casas, M., and Anden, N.E., Eur. J. Pharmacol., 1991, vol. 192, no. 1, pp. 25–30.

    Article  CAS  PubMed  Google Scholar 

  6. Richardson, P.J., Gubitz, A.K., Freeman, T.C., and Dixon, A.K., Adv. Neurol., 1999, vol. 80, pp. 111–119.

    CAS  PubMed  Google Scholar 

  7. Schwarzschild, M.A., Agnati, L., Fuxe, K., Chen, J.F., and Morelli, M., Trends Neurosci., 2006, vol. 29, no. 11, pp. 647–654. doi 10.1016/j.tins.2006.09.004

    Article  CAS  PubMed  Google Scholar 

  8. Boison, D., Curr. Top. Med. Chem., 2011, vol. 11, no. 8, pp. 1068–1086.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tarasova, E.O., Gaidukov, A.E., and Balesina, O.P., Sovr. Probl. Nauki i Obrazovaniya, 2014, no. 3, p. 623.

    Google Scholar 

  10. Sperlágh, B. and Vizi, E.S., Curr. Top. Med. Chem., 2011, vol. 11, no. 8, pp. 1034–1046.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Shiozaki, S., Ichikawa, S., Nakamura, J., Kitamura, S., Yamada, K., and Kuwana, Y., Psychopharmacology (Berl.), 1999, vol. 147, pp. 90–95.

    Article  CAS  Google Scholar 

  12. Correa, M., Wisniecki, A., Betz, A., Dobson, D.R., O’Neill, M.F., O’Neill, M.J., and Salamone, J.D., Behav. Brain Res., 2004, vol. 148, pp. 47–54.

    Article  CAS  PubMed  Google Scholar 

  13. Ivanova, E.A., Zolotov, N.N., Kapitsa, I.G., Pozdnev, V.F., Valdman, E.A., and Voronina, T.A., Immunologiya, 2017, vol. 38, no. 4, pp. 213–218.

    Google Scholar 

  14. Kapitsa, I.G., Ivanova, E.A., Valdman, E.A., and Voronina, T.A., Eksper. Klin. Farmakol., 2017, vol. 80, no. 6, pp. 3–7.

    CAS  Google Scholar 

  15. Cannon, J.R., Tapias, V., Na, H.M., Honick, A.S., Drolet, R.E., and Greenamyre, J.T., Neurobiol. Dis., 2009, vol. 34, no. 2, pp. 279–290. doi 10.1016/j.nbd.2009.01.016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Zolotov, N.N., Kutepova, O.A., Voronina, T.A., Pozdnev, V.F., Smirnov, L.D., and Dyumaev, K.M., Dokl. Akad. Nauk SSSR, 1991, vol. 317, no. 1, pp. 234–237.

    CAS  PubMed  Google Scholar 

  17. Kaplan, N.O., Colowick, S.P., and Ciotti, M.M., J. Biol. Chem., 1952, vol. 194, pp. 579–591.

    CAS  PubMed  Google Scholar 

  18. Seredenin, S.B., Ostrovskaya, R.U., Voronina, T.A., Zolotov, N.N., Yarkova, M.A., and Durnev, A.D., Rus. Patent 2597848, 12.03.2013.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. A. Ivanova.

Additional information

Original Russian Text © E.A. Ivanova, N.N. Zolotov, I.G. Kapitsa, V.F. Pozdnev, E.A. Valdman, T.A. Voronina, 2018, published in Biomeditsinskaya Khimiya.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ivanova, E.A., Zolotov, N.N., Kapitsa, I.G. et al. The Effect of Afobazole and Levodopa on Activity of Proline-Specific Proteinases and Adenosine Deaminase in Serum and Brain Structures of Rats with Experimental Parkinsonism Induced by Systemic Administration of Rotenone. Biochem. Moscow Suppl. Ser. B 12, 186–190 (2018). https://doi.org/10.1134/S1990750818020063

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990750818020063

Keywords

Navigation